Skip to Content

Torecan Dosage

Generic name: thiethylperazine maleate
Dosage form: Tablets, USP and Injection, USP

Medically reviewed on May 11, 2017.

More

Adult

Usual daily dose range is 10 mg to 30 mg.

Oral: One tablet, one to three times daily.

Intramuscular: 2 mL IM, one to three times daily. (See PRECAUTIONS.)

Pediatric Patients

Appropriate dosage of TORECAN® (thiethylperazine) has not been determined in pediatric patients.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Torecan (thiethylperazine)

Consumer resources

Torecan (Advanced Reading)

Professional resources

Torecan (FDA)

Related treatment guides

Nausea/Vomiting

Drug Status

Availability Discontinued

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Drug Class

Phenothiazine antiemetics

Related Drugs

Nausea / Vomiting promethazine, lorazepam, ondansetron, hydroxyzine, Zofran, Ativan, meclizine, Benadryl, diphenhydramine, metoclopramide, Vistaril, prochlorperazine, Reglan, Phenergan, Haldol, Atarax, haloperidol, Compazine, scopolamine, Antivert, chlorpromazine, Thorazine, pyridoxine, perphenazine, Dramamine, More...

Torecan Rating

No reviews - Add your review

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions & Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated June 1st, 2018), Cerner Multum™ (updated July 4th, 2018), Wolters Kluwer™ (updated June 4th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.